Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Revenue

In the fiscal year ending March 31, 2026, Infinium Pharmachem had annual revenue of 1.90B INR with 21.79% growth. Infinium Pharmachem had revenue of 1.06B in the half year ending March 31, 2026, with 42.37% growth.

• Revenue: 1.90B
• Revenue Growth: +21.79%
• P/S Ratio: 1.70
• Revenue / Employee: 13.17M
• Employees: 144
• Market Cap: 3.23B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.90B	339.22M	21.79%
Mar 31, 2025	1.56B	200.50M	14.78%
Mar 31, 2024	1.36B	214.34M	18.76%
Mar 31, 2023	1.14B	151.06M	15.24%
Mar 31, 2022	991.19M	443.60M	81.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 10, 2026

Data Sources Report a data error